{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:14:31Z","timestamp":1793744071954,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-024-00319-w","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T20:32:40Z","timestamp":1722630760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?"],"prefix":"10.1038","volume":"14","author":[{"given":"Francesco Antonio","family":"Mazzotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6461-1824","authenticated-orcid":false,"given":"Lorenzo","family":"Lucaccini Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Popolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Barberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Viti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Di Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"319_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice Committee. 2.","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:17\u201338.","journal-title":"Diabetes Care"},{"key":"319_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.diabres.2011.12.010","volume":"96","author":"M Joubert","year":"2012","unstructured":"Joubert M, Reznik Y. Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use. Diabetes Res Clin Pr. 2012;96:294\u2013305.","journal-title":"Diabetes Res Clin Pr"},{"key":"319_CR3","doi-asserted-by":"publisher","first-page":"108502","DOI":"10.1016\/j.diabres.2020.108502","volume":"170","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Aleppo G. Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pr. 2020;170:108502.","journal-title":"Diabetes Res Clin Pr"},{"key":"319_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593\u2013603.","journal-title":"Diabetes Care"},{"key":"319_CR5","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s13300-021-01160-5","volume":"12","author":"A Janez","year":"2021","unstructured":"Janez A, Battelino T, Klupa T, Kocsis G, Kuricov\u00e1 M, Lalic N, et al. Hybrid closed-loop systems for the treatment of type 1 diabetes: a collaborative, expert group position statement for clinical use in central and eastern Europe. Diabetes Ther. 2021;12:3107\u201335.","journal-title":"Diabetes Ther"},{"key":"319_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2337\/dc20-2250","volume":"44","author":"OJ Collyns","year":"2021","unstructured":"Collyns OJ, Meier RA, Betts ZL, Chan DSH, Frampton C, Frewen CM, et al. Improved glycemic outcomes with medtronic minimed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care. 2021;44:969\u201375.","journal-title":"Diabetes Care"},{"key":"319_CR7","unstructured":"Donnor T, Sarkar S, Feingold KR, Anawalt B, Blackman MR, Boyce A, et al. Insulin-pharmacology, therapeutic regimens and principles of intensive insulin therapy. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc; 2000"},{"key":"319_CR8","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.4239\/wjd.v12.i12.2036","volume":"12","author":"A Nakhleh","year":"2021","unstructured":"Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention. World J Diabetes. 2021;12:2036\u201349.","journal-title":"World J Diabetes"},{"key":"319_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/1932296820918894","volume":"15","author":"RS Rigo","year":"2021","unstructured":"Rigo RS, Levin LE, Belsito DV, Garzon MC, Gandica R, Williams KM. Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus. J Diabetes Sci Technol. 2021;15:786\u201391.","journal-title":"J Diabetes Sci Technol"},{"key":"319_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-020-00468-4","volume":"8","author":"SE Coleman","year":"2020","unstructured":"Coleman SE, Caswell N. Diabetes and eating disorders: an exploration of 'Diabulimia'. BMC Psychol. 2020;8:101.","journal-title":"BMC Psychol"},{"key":"319_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11892-017-0918-8","volume":"17","author":"A Mottalib","year":"2017","unstructured":"Mottalib A, Kasetty M, Mar JY, Elseaidy T, Ashrafzadeh S, Hamdy O. Weight management in patients with type 1 diabetes and obesity. Curr Diab Rep. 2017;17:92.","journal-title":"Curr Diab Rep"},{"key":"319_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/bios11030070","volume":"11","author":"M Pohanka","year":"2021","unstructured":"Pohanka M. Glycated hemoglobin and methods for its point of care testing. Biosens (Basel). 2021;11:70.","journal-title":"Biosens (Basel)"},{"key":"319_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.31128\/AJGP-03-21-5866","volume":"50","author":"M Wang","year":"2021","unstructured":"Wang M, Hng TM. HbA1c: More than just a number. Aust J Gen Pr. 2021;50:628\u201332.","journal-title":"Aust J Gen Pr"},{"key":"319_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-020-01200-7","volume":"20","author":"B Sun","year":"2021","unstructured":"Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20:9.","journal-title":"Cardiovasc Diabetol"},{"key":"319_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.amjms.2018.09.010","volume":"356","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez GE, P Kovatchev B. Glycemic variability: how to measure and its clinical implication for type 2 diabetes. Am J Med Sci. 2018;356:518\u201327.","journal-title":"Am J Med Sci"},{"key":"319_CR16","first-page":"e48998","volume":"15","author":"SMH Ibrahim","year":"2023","unstructured":"Ibrahim SMH, Shahat EA, Amer LA, Aljohani AK. The impact of using carbohydrate counting on managing diabetic patients: a review. Cureus. 2023;15:e48998.","journal-title":"Cureus"},{"key":"319_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/nu10010109","volume":"10","author":"G Tascini","year":"2018","unstructured":"Tascini G, Berioli MG, Cerquiglini L, Santi E, Mancini G, Rogari F, et al. Carbohydrate counting in children and adolescents with type 1 diabetes. Nutrients. 2018;10:109.","journal-title":"Nutrients"},{"key":"319_CR18","first-page":"337","volume":"62","author":"EC Vaz","year":"2018","unstructured":"Vaz EC, Porf\u00edrio GJM, Nunes HRD, Nunes-Nogueira VDS. Effectiveness and safety of carbohydrate counting in the management of adult patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Arch Endocrinol Metab. 2018;62:337\u201345.","journal-title":"Arch Endocrinol Metab"},{"key":"319_CR19","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/nu15194110","volume":"15","author":"A Amorim","year":"2023","unstructured":"Amorim A, Miranda F, Abreu C. In silico validation of personalized safe intervals for carbohydrate counting errors. Nutrients. 2023;15:4110.","journal-title":"Nutrients"},{"key":"319_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1515\/jbcpp-2021-0279","volume":"33","author":"S Palermi","year":"2021","unstructured":"Palermi S, Iacono O, Sirico F, Modestino M, Ruosi C, Spera R, et al. The complex relationship between physical activity and diabetes: an overview. J Basic Clin Physiol Pharm. 2021;33:535\u201347.","journal-title":"J Basic Clin Physiol Pharm"},{"key":"319_CR21","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2337\/dc15-0030","volume":"38","author":"B Bohn","year":"2015","unstructured":"Bohn B, Herbst A, Pfeifer M, Krakow D, Zimny S, Kopp F, et al. Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care. 2015;38:1536\u201343.","journal-title":"Diabetes Care"},{"key":"319_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11892-019-1157-y","volume":"19","author":"DP Barlovic","year":"2019","unstructured":"Barlovic DP, Tikkanen-Dolenc H, Groop PH. Physical activity in the prevention of development and progression of kidney disease in type 1 diabetes. Curr Diab Rep. 2019;19:41.","journal-title":"Curr Diab Rep"},{"key":"319_CR23","doi-asserted-by":"publisher","first-page":"e2022056540","DOI":"10.1542\/peds.2022-056540","volume":"150","author":"S Shorey","year":"2022","unstructured":"Shorey S, Ng ED, Law EC, Wong JCM, Loke KY, Tam WWS. Physical activity and nutrition interventions for type 1 diabetes: a meta-analysis. Pediatrics. 2022;150:e2022056540.","journal-title":"Pediatrics"},{"key":"319_CR24","doi-asserted-by":"crossref","unstructured":"Hormaz\u00e1bal-Aguayo I, Huerta-Uribe N, Mu\u00f1oz-Pardeza J, Ezzatvar Y, Izquierdo M, Garc\u00eda-Hermoso A. Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes. J Clin Endocrinol Metab. 2024;dgae451.","DOI":"10.1210\/clinem\/dgae451"},{"key":"319_CR25","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1083\/jcb.201802095","volume":"217","author":"VL Tokarz","year":"2018","unstructured":"Tokarz VL, MacDonald PE, Klip A. The cell biology of systemic insulin function. J Cell Biol. 2018;217:2273\u201389.","journal-title":"J Cell Biol"},{"key":"319_CR26","doi-asserted-by":"publisher","first-page":"e2633","DOI":"10.1002\/brb3.2633","volume":"12","author":"A Przezak","year":"2022","unstructured":"Przezak A, Bielka W, Mol\u0119da P. Fear of hypoglycemia-An underestimated problem. Brain Behav. 2022;12:e2633.","journal-title":"Brain Behav"},{"key":"319_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11892-016-0762-2","volume":"16","author":"KA Driscoll","year":"2016","unstructured":"Driscoll KA, Raymond J, Naranjo D, Patton SR. Fear of hypoglycemia in children and adolescents and their parents with type 1 diabetes. Curr Diab Rep. 2016;16:77.","journal-title":"Curr Diab Rep"},{"key":"319_CR28","doi-asserted-by":"publisher","first-page":"117955141879879","DOI":"10.1177\/1179551418798794","volume":"11","author":"AA Al Hayek","year":"2018","unstructured":"Al Hayek AA, Robert AA, Al Dawish MA. Skin-related complications among adolescents with type 1 diabetes using insulin pump therapy. Clin Med Insights Endocrinol Diabetes. 2018;11:1179551418798794.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"319_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","volume":"7","author":"S Gentile","year":"2016","unstructured":"Gentile S, Strollo F, Ceriello A, AMD-OSDI Injection Technique Study Group. Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear? Diabetes Ther. 2016;7:401\u20139.","journal-title":"Diabetes Ther"},{"key":"319_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/nu9080906","volume":"9","author":"G Toni","year":"2017","unstructured":"Toni G, Berioli MG, Cerquiglini L, Ceccarini G, Grohmann U, Principi N, et al. Eating disorders and disordered eating symptoms in adolescents with type 1 diabetes. Nutrients. 2017;9:906.","journal-title":"Nutrients"},{"key":"319_CR31","doi-asserted-by":"publisher","first-page":"20nr02707","DOI":"10.4088\/PCC.20nr02707","volume":"22","author":"AS Yahya","year":"2020","unstructured":"Yahya AS, Khawaja S, Chukwuma J, Chukwuma C. Early diagnosis and management of bulimia nervosa in type 1 diabetes. Prim Care Companion CNS Disord. 2020;22:20nr02707.","journal-title":"Prim Care Companion CNS Disord"},{"key":"319_CR32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.12740\/PP\/39536","volume":"49","author":"E Racicka","year":"2015","unstructured":"Racicka E, Bry\u0144ska A. Eating Disorders in children and adolescents with Type 1 and Type 2 Diabetes: prevalence, risk factors, warning signs. Psychiatr Pol. 2015;49:1017\u201324.","journal-title":"Psychiatr Pol"},{"key":"319_CR33","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/dom.13848","volume":"21","author":"N Kietsiriroje","year":"2019","unstructured":"Kietsiriroje N, Pearson S, Campbell M, Ari\u00ebns RAS, Ajjan RA. Double diabetes: A distinct high-risk group? Diabetes Obes Metab. 2019;21:2609\u201318.","journal-title":"Diabetes Obes Metab"},{"key":"319_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","volume":"23","author":"W Bielka","year":"2024","unstructured":"Bielka W, Przezak A, Mol\u0119da P, Pius-Sadowska E, Machali\u0144ski B. Double diabetes\u2014when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc Diabetol. 2024;23:62.","journal-title":"Cardiovasc Diabetol"},{"key":"319_CR35","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s00125-013-2904-2","volume":"56","author":"SJ Cleland","year":"2013","unstructured":"Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR. Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? Diabetologia. 2013;56:1462\u201370.","journal-title":"Diabetologia"},{"key":"319_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41387-019-0101-1","volume":"9","author":"J Khawandanah","year":"2019","unstructured":"Khawandanah J. Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors. Nutr Diabetes. 2019;9:33.","journal-title":"Nutr Diabetes"},{"key":"319_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","volume":"42","author":"TE LaMoia","year":"2021","unstructured":"LaMoia TE, Shulman GI. Cellular and molecular mechanisms of metformin action. Endocr Rev. 2021;42:77\u201396.","journal-title":"Endocr Rev"},{"key":"319_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13300-017-0333-9","volume":"9","author":"G Priya","year":"2018","unstructured":"Priya G, Kalra S. A review of insulin resistance in type 1 diabetes: is there a place for adjunctive metformin? Diabetes Ther. 2018;9:349\u201361.","journal-title":"Diabetes Ther"},{"key":"319_CR39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s00125-017-4364-6","volume":"60","author":"R Livingstone","year":"2017","unstructured":"Livingstone R, Boyle JG, Petrie JR. REMOVAL study team. a new perspective on metformin therapy in type 1 diabetes. Diabetologia. 2017;60:1594\u20131600.","journal-title":"Diabetologia"},{"key":"319_CR40","doi-asserted-by":"publisher","first-page":"721135","DOI":"10.3389\/fendo.2021.721135","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al. GLP-1 receptor agonists: beyond their pancreatic effects. Front Endocrinol (Lausanne). 2021;12:721135.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"319_CR41","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","volume":"46","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Mol Metab. 2021;46:101102.","journal-title":"Mol Metab"},{"key":"319_CR42","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.2337\/dc16-0691","volume":"39","author":"C Mathieu","year":"2016","unstructured":"Mathieu C, Zinman B, Hemmingsson JU, Woo V, Colman P, Christiansen E, et al. Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial. Diabetes Care. 2016;39:1702\u201310.","journal-title":"Diabetes Care"},{"key":"319_CR43","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s13300-018-0496-z","volume":"9","author":"H Warnes","year":"2018","unstructured":"Warnes H, Helliwell R, Pearson SM, Ajjan RA. Metabolic control in type 1 diabetes: is adjunctive therapy the way forward? Diabetes Ther. 2018;9:1831\u201351.","journal-title":"Diabetes Ther"},{"key":"319_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","volume":"19","author":"L Ni","year":"2020","unstructured":"Ni L, Yuan C, Chen G, Zhang C, Wu X. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol. 2020;19:98.","journal-title":"Cardiovasc Diabetol"},{"key":"319_CR45","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.2337\/dc18-1749","volume":"41","author":"J Rosenstock","year":"2018","unstructured":"Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, et al. Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE trials. Diabetes Care. 2018;41:2560\u20139.","journal-title":"Diabetes Care"},{"key":"319_CR46","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.2337\/dc18-1087","volume":"41","author":"P Dandona","year":"2018","unstructured":"Dandona P, Mathieu C, Phillip M, Hansen L, Tsch\u00f6pe D, Thor\u00e9n F, et al. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study. Diabetes Care. 2018;41:2552\u20139.","journal-title":"Diabetes Care"},{"key":"319_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.31083\/j.fbl2805098","volume":"28","author":"Y Ma","year":"2023","unstructured":"Ma Y, Zhao Q, Peng H, Nalisa DL, Shan P, Jiang H. SGLT2i in patients with type 1 diabetes: benefits, risks, and preventive strategies. Front Biosci (Landmark Ed). 2023;28:98.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"319_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.33549\/physiolres.934519","volume":"69","author":"D Vejrazkova","year":"2020","unstructured":"Vejrazkova D, Vankova M, Lukasova P, Vcelak J, Bendlova B. Insights into the physiology of C-peptide. Physiol Res. 2020;69:237\u201343.","journal-title":"Physiol Res"},{"key":"319_CR49","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2337\/db13-0881","volume":"63","author":"JM Lachin","year":"2014","unstructured":"Lachin JM, McGee P, Palmer JP. DCCT\/EDIC Research Group. Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial. Diabetes. 2014;63:739\u201348.","journal-title":"Diabetes"},{"key":"319_CR50","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jama.2023.2063","volume":"329","author":"J McVean","year":"2023","unstructured":"McVean J, Forlenza GP, Beck RW, Bauza C, Bailey R, Buckingham B, et al. Effect of tight glycemic control on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial. JAMA. 2023;329:980\u20139.","journal-title":"JAMA"},{"key":"319_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.curtheres.2019.04.003","volume":"90","author":"S Dong","year":"2019","unstructured":"Dong S, Lau H, Chavarria C, Alexander M, Cimler A, Elliott JP, et al. Effects of periodic intensive insulin therapy: an updated review. Curr Ther Res Clin Exp. 2019;90:61\u201367.","journal-title":"Curr Ther Res Clin Exp"},{"key":"319_CR52","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/17434440.2020.1784724","volume":"17","author":"J Fuchs","year":"2020","unstructured":"Fuchs J, Hovorka R. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy. Expert Rev Med Devices. 2020;17:707\u201320.","journal-title":"Expert Rev Med Devices"},{"key":"319_CR53","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s40265-019-01149-2","volume":"79","author":"R Ramli","year":"2019","unstructured":"Ramli R, Reddy M, Oliver N. Artificial pancreas: current progress and future outlook in the treatment of type 1 diabetes. Drugs 2019;79:1089\u2013101.","journal-title":"Drugs"},{"key":"319_CR54","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1210\/er.2018-00174","volume":"40","author":"RA Lal","year":"2019","unstructured":"Lal RA, Ekhlaspour L, Hood K, Buckingham B. Realizing a closed-loop (artificial pancreas) system for the treatment of type 1 diabetes. Endocr Rev. 2019;40:1521\u201346.","journal-title":"Endocr Rev"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00319-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00319-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00319-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T21:02:13Z","timestamp":1722632533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00319-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1038\/s41387-024-00319-w","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}